“…9,10 Whereas limited data in support of Perclose and StarClose (both from Abbott Vascular, Santa Clara, CA, USA) have been reported, the use of Angio-Seal (St. Jude Medical) has been described in a series of previous reports, suggesting, albeit inconclusively, its feasibility and safety in this setting. [11][12][13] This issue of the Journal reports a compelling single-center cohort study by Lupattelli et al, 14 enrolling 1626 patients undergoing one or more duplex ultrasound-guided antegrade femoral punctures for lower limb revascularization. This registry showed that, in experienced hands, antegrade Angio-Seal deployment can successfully achieve hemostasis in 97.9% of cases, with a 1.1% rate of early complications, a 2.5% rate of 30-day complications, and no later complications associated with the device.…”